{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA and EMA Provide Guiding Principles for AI in Drug Development",
    "url": "https://www.lexblog.com/2026/01/27/fda-and-ema-provide-guiding-principles-for-ai-in-drug-development-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-4YCMKECA",
        "url": "https://www.lexblog.com/lib/4YCMKECA/"
    },
    "datePublished": "2026-01-27T16:04:33-05:00",
    "dateModified": "2026-01-28T14:13:14-05:00",
    "author": {
        "@type": "Person",
        "name": "Craig B. Bleifer, Allyson M. Maur, Jessica L. Vaughn, Ph.D., Bryan S. Walsh"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "McGuireWoods LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "One-Stop Shop",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.onestopshopnews.com/?p=2244",
    "sourceStability": "may-move"
}